Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder Cancer

Thomas J. Guzzo, Ahmed Magheli, Trinity J. Bivalacqua, Matthew E. Nielsen, Frank J. Attenello, Mark P. Schoenberg, Mark L. Gonzalgo

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objectives: To compare the outcomes of patients who were upstaged to pT2 at the time of radical cystectomy (RC) to those who were correctly staged as T2 before RC. Methods: The clinical and pathologic data were reviewed of 496 patients who underwent RC from 1994 to 2008. Patients who underwent RC for high-grade T1 (HGT1) or carcinoma in situ (CIS) (184) were compared with those with known muscle-invasive cancer (312) before RC. Patients were substratified based on preoperative intravesical therapy status. Recurrence-free survival (RFS) for patients who were upstaged to muscle-invasive disease was compared with patients who were correctly staged T2 preoperatively. Results: Patients who were upstaged to pT2 disease had significantly worse 3- and 5-year RFS compared with those who where accurately staged (cT2 = pT2) (64% and 61% vs 83% and 74%, respectively; P = .04). Upstaging to pT2 in patients with a history of bacillus Calmette-Guerin treatment resulted in worse 3- and 5-year RFS rates compared with those accurately staged (69% and 57% vs 100% and 86%, respectively; P = .03). Conclusions: Upstaging to pT2 among patients with HGT1 or CIS is associated with worse RFS compared with patients with known muscle invasion before RC (HGT1/CIS = pT2 vs cT2 = pT2). This finding was most significant among patients with a history of bacillus Calmette-Guerin treatment. Factors such as understaging of disease or treatment delay may contribute to worse outcomes among this subset of patients and should be considered when discussing treatment options.

Original languageEnglish (US)
Pages (from-to)1276-1280
Number of pages5
JournalUrology
Volume74
Issue number6
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Cystectomy
Mycobacterium bovis
Urinary Bladder Neoplasms
Recurrence
Survival
Carcinoma in Situ
Muscle Neoplasms
Therapeutics
Muscles
Survival Rate

ASJC Scopus subject areas

  • Urology

Cite this

Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder Cancer. / Guzzo, Thomas J.; Magheli, Ahmed; Bivalacqua, Trinity J.; Nielsen, Matthew E.; Attenello, Frank J.; Schoenberg, Mark P.; Gonzalgo, Mark L.

In: Urology, Vol. 74, No. 6, 12.2009, p. 1276-1280.

Research output: Contribution to journalArticle

Guzzo, Thomas J. ; Magheli, Ahmed ; Bivalacqua, Trinity J. ; Nielsen, Matthew E. ; Attenello, Frank J. ; Schoenberg, Mark P. ; Gonzalgo, Mark L. / Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder Cancer. In: Urology. 2009 ; Vol. 74, No. 6. pp. 1276-1280.
@article{b3cee161dbb748b5a9056ed6a29e6c63,
title = "Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder Cancer",
abstract = "Objectives: To compare the outcomes of patients who were upstaged to pT2 at the time of radical cystectomy (RC) to those who were correctly staged as T2 before RC. Methods: The clinical and pathologic data were reviewed of 496 patients who underwent RC from 1994 to 2008. Patients who underwent RC for high-grade T1 (HGT1) or carcinoma in situ (CIS) (184) were compared with those with known muscle-invasive cancer (312) before RC. Patients were substratified based on preoperative intravesical therapy status. Recurrence-free survival (RFS) for patients who were upstaged to muscle-invasive disease was compared with patients who were correctly staged T2 preoperatively. Results: Patients who were upstaged to pT2 disease had significantly worse 3- and 5-year RFS compared with those who where accurately staged (cT2 = pT2) (64{\%} and 61{\%} vs 83{\%} and 74{\%}, respectively; P = .04). Upstaging to pT2 in patients with a history of bacillus Calmette-Guerin treatment resulted in worse 3- and 5-year RFS rates compared with those accurately staged (69{\%} and 57{\%} vs 100{\%} and 86{\%}, respectively; P = .03). Conclusions: Upstaging to pT2 among patients with HGT1 or CIS is associated with worse RFS compared with patients with known muscle invasion before RC (HGT1/CIS = pT2 vs cT2 = pT2). This finding was most significant among patients with a history of bacillus Calmette-Guerin treatment. Factors such as understaging of disease or treatment delay may contribute to worse outcomes among this subset of patients and should be considered when discussing treatment options.",
author = "Guzzo, {Thomas J.} and Ahmed Magheli and Bivalacqua, {Trinity J.} and Nielsen, {Matthew E.} and Attenello, {Frank J.} and Schoenberg, {Mark P.} and Gonzalgo, {Mark L.}",
year = "2009",
month = "12",
doi = "10.1016/j.urology.2009.05.092",
language = "English (US)",
volume = "74",
pages = "1276--1280",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder Cancer

AU - Guzzo, Thomas J.

AU - Magheli, Ahmed

AU - Bivalacqua, Trinity J.

AU - Nielsen, Matthew E.

AU - Attenello, Frank J.

AU - Schoenberg, Mark P.

AU - Gonzalgo, Mark L.

PY - 2009/12

Y1 - 2009/12

N2 - Objectives: To compare the outcomes of patients who were upstaged to pT2 at the time of radical cystectomy (RC) to those who were correctly staged as T2 before RC. Methods: The clinical and pathologic data were reviewed of 496 patients who underwent RC from 1994 to 2008. Patients who underwent RC for high-grade T1 (HGT1) or carcinoma in situ (CIS) (184) were compared with those with known muscle-invasive cancer (312) before RC. Patients were substratified based on preoperative intravesical therapy status. Recurrence-free survival (RFS) for patients who were upstaged to muscle-invasive disease was compared with patients who were correctly staged T2 preoperatively. Results: Patients who were upstaged to pT2 disease had significantly worse 3- and 5-year RFS compared with those who where accurately staged (cT2 = pT2) (64% and 61% vs 83% and 74%, respectively; P = .04). Upstaging to pT2 in patients with a history of bacillus Calmette-Guerin treatment resulted in worse 3- and 5-year RFS rates compared with those accurately staged (69% and 57% vs 100% and 86%, respectively; P = .03). Conclusions: Upstaging to pT2 among patients with HGT1 or CIS is associated with worse RFS compared with patients with known muscle invasion before RC (HGT1/CIS = pT2 vs cT2 = pT2). This finding was most significant among patients with a history of bacillus Calmette-Guerin treatment. Factors such as understaging of disease or treatment delay may contribute to worse outcomes among this subset of patients and should be considered when discussing treatment options.

AB - Objectives: To compare the outcomes of patients who were upstaged to pT2 at the time of radical cystectomy (RC) to those who were correctly staged as T2 before RC. Methods: The clinical and pathologic data were reviewed of 496 patients who underwent RC from 1994 to 2008. Patients who underwent RC for high-grade T1 (HGT1) or carcinoma in situ (CIS) (184) were compared with those with known muscle-invasive cancer (312) before RC. Patients were substratified based on preoperative intravesical therapy status. Recurrence-free survival (RFS) for patients who were upstaged to muscle-invasive disease was compared with patients who were correctly staged T2 preoperatively. Results: Patients who were upstaged to pT2 disease had significantly worse 3- and 5-year RFS compared with those who where accurately staged (cT2 = pT2) (64% and 61% vs 83% and 74%, respectively; P = .04). Upstaging to pT2 in patients with a history of bacillus Calmette-Guerin treatment resulted in worse 3- and 5-year RFS rates compared with those accurately staged (69% and 57% vs 100% and 86%, respectively; P = .03). Conclusions: Upstaging to pT2 among patients with HGT1 or CIS is associated with worse RFS compared with patients with known muscle invasion before RC (HGT1/CIS = pT2 vs cT2 = pT2). This finding was most significant among patients with a history of bacillus Calmette-Guerin treatment. Factors such as understaging of disease or treatment delay may contribute to worse outcomes among this subset of patients and should be considered when discussing treatment options.

UR - http://www.scopus.com/inward/record.url?scp=70749140223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70749140223&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2009.05.092

DO - 10.1016/j.urology.2009.05.092

M3 - Article

VL - 74

SP - 1276

EP - 1280

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -